Ghaziabad
Open Emergency Modal

Lymphoma Treatment in Ghaziabad

Even as lymphoma is frequently associated with leukaemia, these are two very different disorders with unique symptoms, staging methods and approaches to therapy. What causes lymphoma to be particularly tricky for patients is its variety, as lymphoma includes many unique types, ranging from indolent forms that can be followed up without any treatment for years, to fast-growing variants, which demand immediate chemotherapy following diagnosis. This guide explains what lymphoma is, its classification and staging methods, the symptoms observed (including skin and neurological symptoms), and how treatment is provided — as an entire pathway is accessible locally in Ghaziabad through the Hemato-Oncology department at Yashoda Medicity.

What Is Lymphoma?  

Lymphoma, also known as lymphatic cancer, is a cancer of the lymphatic system, which consists of lymph nodes, the spleen, the thymus glands, and lymphoid tissues that are an important part of the body’s immune system. This type of cancer occurs when lymphocytes, a type of white blood cell, begin to multiply abnormally. Lymphoma tends to develop anywhere in the body because lymphatic tissues are distributed throughout the body.

Types Of Lymphoma  

Lymphomas are broadly classified into two main types and many specific subtypes under each:

Hodgkin Lymphoma (HL): With the characteristic feature of an abnormal cell (Reed-Sternberg cell), Hodgkin's lymphoma usually grows in a predictable and orderly way from one group of lymph nodes to the next. This lymphoma has a better prognosis than many other cancers because it follows a predictable growth pattern. There are distinct bimodal peaks, with most people being diagnosed in their twenties or above sixty years old.

  • Non-Hodgkin Lymphoma (NHL): This is a diverse family of cancers that accounts for the vast majority of lymphomas, with over 60 types recognized under this heading. Two of the significant non-Hodgkin lymphoma subtypes are:
  • Diffuse Large B-cell Lymphoma (DLBCL): The most common of aggressive lymphoma subtypes. Though it grows fast, it is curable with combination immunochemotherapy and thus an exception to the term "aggressive" in oncology.
  • Cutaneous T-Cell Lymphoma (CTCL) – this type of NHL is less common; it affects the skin rather than the lymph nodes, usually manifesting as either Mycosis Fungoides or its advanced form, Sézary syndrome. This disease is often mistaken for eczema or psoriasis because, at the outset, CTCL presents as a skin condition.

Subtypes of lymphoma are classified according to the growth pattern: low-grade (indolent) lymphomas (for example, follicular lymphoma) develop slowly and sometimes are just watched for some time without treatment; however, high-grade (aggressive) lymphomas (DLBCL and Burkitt lymphoma, for instance) grow fast and demand immediate treatment, although they are usually more sensitive to chemotherapy and thus more curable.

What Causes Lymphoma?  

Unlike most other types of cancer, there is not one definite cause of most cases of lymphoma, though a number of risk factors are known:

  • Impaired immune system: Such as people with HIV/AIDS, immunosuppressive effects following organ transplantation, or various congenital immune deficiencies 
  • Various infections:  The Epstein-Barr virus is related to some Hodgkin and Burkitt lymphomas, Helicobacter pylori infection is associated with a specific type of gastric MALT lymphoma, and Hepatitis C infection is associated with certain NHLs
  • Various autoimmune disorders:  Including rheumatoid arthritis, Sjögren’s syndrome and coeliac disease, which are associated with an increased risk of NHL 
  • Age:  Increased risk of most types of NHL with age, though the case of Hodgkin lymphoma has its characteristic bimodal distribution among younger and older adults 
  • Family history:  In some cases

Lymphoma Symptoms  

  • Painless swollen lymph nodes — in the neck, underarm or groin — the most recognisable lymphoma symptom 
  • "B symptoms" — a specific, clinically important trio of fever, drenching night sweats and unexplained weight loss (more than roughly 10% of body weight over 6 months), which also factor directly into staging 
  •  Persistent fatigue 
  •  Unexplained itching (pruritus), notably associated with Hodgkin lymphoma, sometimes occurring without any visible rash 
  • Cough or breathlessness, if lymph nodes in the chest are involved 
  • Abdominal bloating or discomfort, if the spleen or abdominal lymph nodes are involved 

Lymphoma Rash & Cutaneous T-Cell Lymphoma 

"Lymphoma rash" usually refers to one of two conditions, and it would be appropriate to distinguish between them. The first one is a rash-like symptom characterized by generalized itching without any skin changes, and this can happen in systemic lymphoma, especially in Hodgkin's lymphoma, as a paraneoplastic syndrome, i.e., not the result of skin manifestations but the effect of the entire body reaction. The second one is Cutaneous T-Cell Lymphoma (CTCL), and it is a condition wherein a lymphoma starts in the skin and manifests itself as a rash, i.e., persistent itchy or non-itching scaly patches or plaques on the trunk, buttocks, and other sun-protected areas. Because CTCL lesions can resemble eczema, psoriasis, or fungal infections, a CTCL diagnosis is often delayed for months or even years until all other possibilities have been ruled out.

Symptoms Of Lymphoma In Females  

Lymphoma symptoms, including lymphadenopathy, fatigue, B symptoms, and pruritus, do not differ in their nature or severity in females and males, and the approach to the workup of suspected lymphoma will remain the same for both sexes. Still, there are certain points to remember regarding women only: primary breast lymphoma is a rare variant of NHL which manifests with a breast mass, sometimes confusing the diagnosis with breast cancer, until biopsy helps to resolve the problem. Any breast mass requires interventions, but not an assumption of one diagnosis or another. Involvement of the pelvic or inguinal lymph nodes might result in pelvic pain, being mistaken for gynecologic pathology at first. Again, the general idea holds for anyone: unexplained lymph node enlargement and/or B symptoms should not be automatically attributed to a more aggressive disease.

 CNS Lymphoma  

CNS (Central Nervous System) primary lymphoma is an uncommon subtype of NHL that arises directly in the brain, spinal cord, or eyes, rather than in the lymph nodes. It is more prevalent in individuals with a compromised immune system (HIV-infected persons and transplant recipients) but may also occur in individuals with intact immunity, particularly among older adults. 

Because it occurs in the brain rather than the lymph nodes, CNS lymphoma does not present with swollen glands, as is common with nodal lymphoma, but instead produces symptoms similar to those of brain tumors, such as disorientation, changes in personality, weakness, convulsions, and impaired vision. Its treatment also differs from the standard lymphoma chemotherapy regimen because most of these regimens are ineffective in crossing the blood-brain barrier; CNS lymphoma is thus treated with chemotherapy using methotrexate.

Diagnosing Lymphoma — and What "Lymphoma Removal" Actually Means  

Let’s address the most common misunderstanding about the treatment of lymphomas from the very start: unlike solid tumors, lymphoma is never surgically "removed" because it affects lymphatic tissue, which is widespread throughout the body rather than limited to one area. Surgery plays an exclusively diagnostic role in the case of lymphoma – lymph node excision biopsy, which involves removal of the enlarged lymph node and microscopic examination of the tumor, still remains the most effective method to make sure that the patient does indeed have a lymphoma and which subtype it is (needle biopsy cannot provide sufficient material for accurate subtyping). Surgical interventions rarely occur after that step and only in highly individual cases, when chemotherapy, immunotherapy and radiotherapy are used as the main methods of treatment.

  • Lymph node excision biopsy: The main diagnostic procedure, providing material for microscopic and molecular testing
  • CT, PET-CT and sometimes MRI: For staging and determination of all affected areas 
  • Bone marrow biopsy: For the detection of marrow involvement in selected cases 

Immunohistochemistry and molecular/genetic testing – for precise lymphoma subtyping, which has a great influence on the treatment strategy

Lymphoma Stages  

Lymphoma is staged using the Ann Arbor system (as refined by the Lugano classification), based on how many lymph node regions are involved and whether disease has spread beyond the lymphatic system: 

  • Stage I: Involvement of a single lymph node region or a single organ outside the lymphatic system.
  • Stage II: Two or more lymph node regions on the same side of the diaphragm.
  • Stage III: Lymph node regions on both sides of the diaphragm.
  • Stage IV: Widespread involvement of one or more organs beyond the lymphatic system, such as the bone marrow, liver, or lungs.

Each stage also carries an "A" or "B" suffix depending on whether B symptoms (fever, night sweats, weight loss) are present, since their presence affects both prognosis and treatment intensity.

Lymphoma Survival Rate  

As with any cancer statistic, survival rates vary enormously by subtype, stage, age and response to treatment — broad averages are a starting reference point, not a personal prediction, and your specific prognosis is best discussed directly with your treating haematologist. As general reference points from widely cited international data: 

  • Hodgkin lymphoma has one of the more favourable outlooks among cancers overall, with 5-year relative survival commonly cited in the 85-90%+ range, particularly for early-stage disease in younger patients.
  • DLBCL, despite being an aggressive lymphoma, has a 5-year relative survival commonly cited around 60-65% with standard immunochemotherapy, and is frequently curable, especially when caught before advanced-stage spread.
  • Follicular lymphoma (a common indolent NHL) is associated with a 5-year relative survival commonly cited above 90%, though it often follows a chronic, relapsing-and-remitting course over many years rather than being cured outright with a single treatment course.
  • CNS lymphoma has historically carried a more guarded prognosis than systemic lymphoma, though outcomes have improved meaningfully with modern high-dose methotrexate-based treatment protocols.

Lymphoma Treatment  

  • Combination immunochemotherapy: R-CHOP (rituximab plus a combination of four chemotherapy drugs) remains the first-line treatment for DLBCL and certain other B-cell lymphomas, usually delivered in cycles over several months.
  • Advanced Radiotherapy: Applied to localized disease, post-chemotherapy consolidation in selected patients, and as a cornerstone of early-stage CTCL management. When radiation therapy is indicated, modern ultra-precise platforms are used to target involved lymph nodes while sparing surrounding healthy tissues. These high-precision technologies include Varian ETHOS with HYPERSIGHT and IDENTIFY Technology for adaptive, real-time treatment. Varian EDGE with HyperArc and Brainlab ExacTrac Dynamic for pinpoint delivery. Elekta Unity MR-Linac for MRI-guided precision; and high-dose-rate brachytherapy systems such as Varian Bravos. 
  • Targeted therapy and immunotherapy: Involving new antibodies and small molecule therapy targeted at different lymphoma subtypes.
  • CAR-T cells and other cellular therapy: Applied to certain selected cases of relapse or resistance, with support of the Cell and Gene Therapy Lab.
  • Bone Marrow / Stem Cell Transplantation: Autologous or allogeneic in selected cases of relapse or high risk.
  • Watchful waiting: An approach applicable to certain slow-growing asymptomatic indolent lymphomas where no difference in outcome is observed between active treatment and treatment upon progression.

Why Choose Yashoda Medicity For Lymphoma Treatment In Ghaziabad  

  • Hemato-Oncology under the leadership of Dr. Nivedita Dhingra, Director and Head of Hematology, Hemato-Oncology and Bone Marrow Transplant (Adult & Paediatric) along with Dr. Karuna Jha, Senior Consultant 
  • In-house diagnostic pathway with excision biopsy, PET-CT/MRI staging and molecular-genetic typing for proper categorization before beginning therapy 
  • Day-care chemotherapy and immunotherapy clinics for both simple and complicated treatments 
  • Bone Marrow Transplant programme for adults and children along with a Cell & Gene Therapy Laboratory for difficult/relapsed patients 
  • Multi-disciplinary tumor board discussion for each case, including cooperation between dermatology for cutaneous lymphomas and neuro-oncology for CNS lymphomas 
  • Complete pathway accessible locally in Ghaziabad, without coordinating the entire treatment process at different hospitals in Delhi

Book a Consultation

If you've noticed persistent, painless swelling in a lymph node, unexplained fevers, night sweats or weight loss, or a skin condition that isn't responding to standard treatment, an early haematology evaluation gives the clearest picture and the widest range of treatment options. To book a consultation with the Hemato-Oncology team at Yashoda Medicity, Ghaziabad, call +91 9266610101 or use the online booking form on this page. 

Yashoda Medicity: Yashoda Medicity, Hospital Plot, Shakti Khand 2, Indirapuram, Ghaziabad, Uttar Pradesh - 201014  |  Phone: +91 9266610101

Meet Our Expert Medical Team

Dr. Jigar Paghadar
Dr. Jigar Paghadar

Junior Consultant

Dr. Nikhil Tandon
Dr. Nikhil Tandon

Consultant

Dr. Nishtha Sachdeva
Dr. Nishtha Sachdeva

Consultant

Dr. Manish Singhal
Dr. Manish Singhal

Vice Chairman

Dr. Nivedita Dhingra
Dr. Nivedita Dhingra

Director & Head

Dr. Karuna Jha
Dr. Karuna Jha

Senior Consultant

Dr. Hemlata Garg
Dr. Hemlata Garg

Consultant

Dr. Ipshita Sahoo
Dr. Ipshita Sahoo

Associate Consultant

Dr. Satinder Kaur
Dr. Satinder Kaur

Senior Director and Head

Dr. Abhishek Yadav
Dr. Abhishek Yadav

Director

Dr. Gagan Saini
Dr. Gagan Saini

Vice-Chairman & Head

Dr. Rashmi Shukla
Dr. Rashmi Shukla

Principal Consultant

Our Technological Advancements

Patient Testimonials

Frequently Asked Questions

Not quite. Leukaemia is a form of cancer affecting mainly the blood and bone marrow, while lymphoma is a cancer of the lymph nodes and lymphatic system. There can be some overlap, such as CLL and SLL representing closely related forms of the same disease, but their presentation, staging, and treatment may differ.

Not usually. Since lymphatic tissue is found throughout the body, surgery is generally not used as the primary treatment for lymphoma, unlike many solid tumours. Surgery may be performed for diagnostic purposes, such as removing a lymph node for biopsy to confirm the diagnosis.

The appearance depends on the type of lymphoma. Cutaneous T-cell lymphoma can cause patches or raised plaques resembling eczema or psoriasis and may cause itching. Some systemic lymphomas, including Hodgkin lymphoma, can also cause generalised itching without a visible rash.

Survival for Diffuse Large B-cell Lymphoma (DLBCL) varies according to factors such as disease stage, age, overall health, risk profile, and response to treatment. DLBCL is potentially curable in many patients, and an oncologist or haematologist can provide a more personalised prognosis based on the individual case.

Lymphoma is commonly classified from Stage I through Stage IV using the Lugano classification, based on the extent and location of lymph node and extranodal involvement. Symptoms such as unexplained fever, night sweats, and weight loss are also considered when assessing the disease.

Main Speciality


Speciality in Location